Cargando…

Protection against Chlamydia Promoted by a Subunit Vaccine (CTH1) Compared with a Primary Intranasal Infection in a Mouse Genital Challenge Model

BACKGROUND: The chlamydial proteins CT443 (OmcB) and CT521 (rl16) have previously been identified as human B and/or T cell targets during a chlamydial infection in humans. Here we compare the protective effector mechanism promoted by a fusion protein composed of CT521 and CT443 (CTH1) with a primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsen, Anja Weinreich, Theisen, Michael, Christensen, Dennis, Follmann, Frank, Andersen, Peter
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874006/
https://www.ncbi.nlm.nih.gov/pubmed/20505822
http://dx.doi.org/10.1371/journal.pone.0010768
_version_ 1782181428858978304
author Olsen, Anja Weinreich
Theisen, Michael
Christensen, Dennis
Follmann, Frank
Andersen, Peter
author_facet Olsen, Anja Weinreich
Theisen, Michael
Christensen, Dennis
Follmann, Frank
Andersen, Peter
author_sort Olsen, Anja Weinreich
collection PubMed
description BACKGROUND: The chlamydial proteins CT443 (OmcB) and CT521 (rl16) have previously been identified as human B and/or T cell targets during a chlamydial infection in humans. Here we compare the protective effector mechanism promoted by a fusion protein composed of CT521 and CT443 (CTH1) with a primary intranasal Chlamydia muridarum infection known to provide high levels of protection against a genital chlamydial challenge. METHODOLOGY/PRINCIPAL FINDINGS: The fusion protein CTH1, adjuvanted with a strong Th1 inducing cationic adjuvant (CAF01), significantly reduced the bacterial shedding compared to a control group in both a C. trachomatis Serovar D and C. muridarum challenge model. The CTH1/CAF01 vaccine was found to induce polyfunctional T cells consisting of TNFα/IL-2 and TNFα/IL-2/IFN-γ positive cells and high titers of CTH1 specific IgG2a and IgG1. By depletion experiments the protection in the C. muridarum challenge model was demonstrated to be mediated solely by CD4(+) T cells. In comparison, an intranasal infection with C. muridarum induced a T cell response that consisted predominantly of TNFα/IFN-γ co-expressing effector CD4(+) T cells and an antibody response consisting of C. muridarum specific IgG1, IgG2a but also IgA. This response was associated with a high level of protection against challenge—a protection that was only partially dependent on CD4(+) T cells. Furthermore, whereas the antibody response induced by intranasal infection was strongly reactive against the native antigens displayed in the chlamydial elementary body, only low levels of antibodies against this preparation were found after CTH1/CAF01 immunization. CONCLUSIONS/SIGNIFICANCE: Our data demonstrate that CTH1 vaccination promotes a CD4(+) T cell dependent protective response but compared with intranasal C. muridarum infection lacks a CD4 independent protective mechanism for complete protection.
format Text
id pubmed-2874006
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-28740062010-05-26 Protection against Chlamydia Promoted by a Subunit Vaccine (CTH1) Compared with a Primary Intranasal Infection in a Mouse Genital Challenge Model Olsen, Anja Weinreich Theisen, Michael Christensen, Dennis Follmann, Frank Andersen, Peter PLoS One Research Article BACKGROUND: The chlamydial proteins CT443 (OmcB) and CT521 (rl16) have previously been identified as human B and/or T cell targets during a chlamydial infection in humans. Here we compare the protective effector mechanism promoted by a fusion protein composed of CT521 and CT443 (CTH1) with a primary intranasal Chlamydia muridarum infection known to provide high levels of protection against a genital chlamydial challenge. METHODOLOGY/PRINCIPAL FINDINGS: The fusion protein CTH1, adjuvanted with a strong Th1 inducing cationic adjuvant (CAF01), significantly reduced the bacterial shedding compared to a control group in both a C. trachomatis Serovar D and C. muridarum challenge model. The CTH1/CAF01 vaccine was found to induce polyfunctional T cells consisting of TNFα/IL-2 and TNFα/IL-2/IFN-γ positive cells and high titers of CTH1 specific IgG2a and IgG1. By depletion experiments the protection in the C. muridarum challenge model was demonstrated to be mediated solely by CD4(+) T cells. In comparison, an intranasal infection with C. muridarum induced a T cell response that consisted predominantly of TNFα/IFN-γ co-expressing effector CD4(+) T cells and an antibody response consisting of C. muridarum specific IgG1, IgG2a but also IgA. This response was associated with a high level of protection against challenge—a protection that was only partially dependent on CD4(+) T cells. Furthermore, whereas the antibody response induced by intranasal infection was strongly reactive against the native antigens displayed in the chlamydial elementary body, only low levels of antibodies against this preparation were found after CTH1/CAF01 immunization. CONCLUSIONS/SIGNIFICANCE: Our data demonstrate that CTH1 vaccination promotes a CD4(+) T cell dependent protective response but compared with intranasal C. muridarum infection lacks a CD4 independent protective mechanism for complete protection. Public Library of Science 2010-05-21 /pmc/articles/PMC2874006/ /pubmed/20505822 http://dx.doi.org/10.1371/journal.pone.0010768 Text en Olsen et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Olsen, Anja Weinreich
Theisen, Michael
Christensen, Dennis
Follmann, Frank
Andersen, Peter
Protection against Chlamydia Promoted by a Subunit Vaccine (CTH1) Compared with a Primary Intranasal Infection in a Mouse Genital Challenge Model
title Protection against Chlamydia Promoted by a Subunit Vaccine (CTH1) Compared with a Primary Intranasal Infection in a Mouse Genital Challenge Model
title_full Protection against Chlamydia Promoted by a Subunit Vaccine (CTH1) Compared with a Primary Intranasal Infection in a Mouse Genital Challenge Model
title_fullStr Protection against Chlamydia Promoted by a Subunit Vaccine (CTH1) Compared with a Primary Intranasal Infection in a Mouse Genital Challenge Model
title_full_unstemmed Protection against Chlamydia Promoted by a Subunit Vaccine (CTH1) Compared with a Primary Intranasal Infection in a Mouse Genital Challenge Model
title_short Protection against Chlamydia Promoted by a Subunit Vaccine (CTH1) Compared with a Primary Intranasal Infection in a Mouse Genital Challenge Model
title_sort protection against chlamydia promoted by a subunit vaccine (cth1) compared with a primary intranasal infection in a mouse genital challenge model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874006/
https://www.ncbi.nlm.nih.gov/pubmed/20505822
http://dx.doi.org/10.1371/journal.pone.0010768
work_keys_str_mv AT olsenanjaweinreich protectionagainstchlamydiapromotedbyasubunitvaccinecth1comparedwithaprimaryintranasalinfectioninamousegenitalchallengemodel
AT theisenmichael protectionagainstchlamydiapromotedbyasubunitvaccinecth1comparedwithaprimaryintranasalinfectioninamousegenitalchallengemodel
AT christensendennis protectionagainstchlamydiapromotedbyasubunitvaccinecth1comparedwithaprimaryintranasalinfectioninamousegenitalchallengemodel
AT follmannfrank protectionagainstchlamydiapromotedbyasubunitvaccinecth1comparedwithaprimaryintranasalinfectioninamousegenitalchallengemodel
AT andersenpeter protectionagainstchlamydiapromotedbyasubunitvaccinecth1comparedwithaprimaryintranasalinfectioninamousegenitalchallengemodel